The BioPharma Dive Awards for 2019
From AstraZeneca to Zolgensma, these are the companies, executives and drugs that shaped the biopharma industry this year. Check out who won below:
Biotech of the Year: Galapagos
Pharma of the Year: AstraZeneca
Executive of the Year: Josh Bilenker, Loxo Oncology
Readout of the Year: Aducanumab’s surprise revival
Disruptor of the Year: The Federal Trade Commission
Drug Launch of the Year: Zolgensma
Deal of the Year: Bristol-Myers Squibb buys Celgene
